MedTrace Logo

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

NCT01885910 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-02-27

Study results available
· View outcomes & findings →

Summary

This pilot study will explore if continuation of treatment of treatment with Aczone 5% gel following combination treatment with with doxycycline and Aczone 5% gel can maintain therapeutic response.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Doxycycline 100mg

Doxycycline 100mg by mouth once daily

DRUG

Aczone 5% gel

Aczone 5% gel twice daily

Sponsors & Collaborators

  • WFH MEDICAL, LLC

    collaborator OTHER

  • Derm Research, PLLC

    lead OTHER

Principal Investigators

  • Leon H Kircik, MD · DermResearch, PLLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01885910 on ClinicalTrials.gov